As of 2025-11-07, the Relative Valuation of Adaptive Biotechnologies Corp (ADPT) is (24.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.56 USD, the upside of Adaptive Biotechnologies Corp based on Relative Valuation is -255.5%.
The range of the Relative Valuation is (26.56) - (25.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 33.4x - 45.3x | 38.4x |
| Forward P/E multiples | 19.5x - 32.6x | 22.4x |
| Fair Price | (26.56) - (25.92) | (24.20) |
| Upside | -270.7% - -266.6% | -255.5% |
| Date | P/E |
| 2025-11-06 | -19.54 |
| 2025-11-05 | -22.09 |
| 2025-11-04 | -21.25 |
| 2025-11-03 | -21.78 |
| 2025-10-31 | -21.81 |
| 2025-10-30 | -21.24 |
| 2025-10-29 | -21.10 |
| 2025-10-28 | -21.23 |
| 2025-10-27 | -21.50 |
| 2025-10-24 | -21.63 |
| 2025-10-23 | -21.55 |
| 2025-10-22 | -20.66 |
| 2025-10-21 | -21.79 |
| 2025-10-20 | -22.40 |
| 2025-10-17 | -20.47 |
| 2025-10-16 | -21.69 |
| 2025-10-15 | -21.49 |
| 2025-10-14 | -19.57 |
| 2025-10-13 | -19.47 |
| 2025-10-10 | -19.05 |
| 2025-10-09 | -19.66 |
| 2025-10-08 | -19.53 |
| 2025-10-07 | -18.02 |
| 2025-10-06 | -18.18 |
| 2025-10-03 | -18.06 |
| 2025-10-02 | -17.89 |
| 2025-10-01 | -18.29 |
| 2025-09-30 | -18.79 |
| 2025-09-29 | -16.91 |
| 2025-09-26 | -16.61 |
| 2025-09-25 | -16.49 |
| 2025-09-24 | -16.10 |
| 2025-09-23 | -17.50 |
| 2025-09-22 | -17.51 |
| 2025-09-19 | -16.78 |
| 2025-09-18 | -17.30 |
| 2025-09-17 | -16.10 |
| 2025-09-16 | -16.22 |
| 2025-09-15 | -16.43 |
| 2025-09-12 | -15.84 |
| 2025-09-11 | -16.94 |
| 2025-09-10 | -15.60 |
| 2025-09-09 | -15.84 |
| 2025-09-08 | -15.75 |
| 2025-09-05 | -16.14 |
| 2025-09-04 | -16.35 |
| 2025-09-03 | -16.14 |
| 2025-09-02 | -16.13 |
| 2025-08-29 | -16.55 |
| 2025-08-28 | -16.72 |